Table 2.
Dose | 1 × 105 cells/kg Low dose |
5 × 105 cells/kg Medium dose |
1 × 106 cells/kg High dose |
---|---|---|---|
Variable | |||
Lymphocytex109/L (median [IQR]) | |||
Pre | 0.79 [0.72] | 1.33 [0.75] | 1.01 [0.65] |
Week 1 | 1.76 [1.48] | 2.02 [2.57] | 1.77 [2.03] |
Week 2 | 2.19 [0.45] | 2.40 | 1.87 |
CD3+ cells x109/L (median [IQR]) | |||
Pre | N/D | 0.85 [0.57] | 0.77 [0.26] |
Week 1 | 1.11 [0.26] | 1.34 [2.06] | 1.32 [1.44] |
Week 2 | 1.68 [0.27] | 1.54 | 1.51 |
CD4+ cells x109/L (median [IQR]) | |||
Pre | N/D | 0.61 [0.42] | 0.61 [0.51] |
Week 1 | 0.68 [0.20] | 1.04 [1.5] | 1.16 [1.25] |
Week 2 | 0.77 [0.28] | 1.21 | 1.21 |
CD8+ cells x109/L (median [IQR]) | |||
Pre | N/D | 0.13 [0.08] | 0.15 [0.24] |
Week 1 | 0.32 [0.12] | 0.26 [0.44] | 0.21 [0.28] |
Week 2 | 0.81 [0.69] | 0.26 | 0.32 |
NK cells x109/L (median [IQR]) | |||
Pre | N/D | 0.27 [0.13] | 0.24 [0.33] |
Week 1 | 0.14 [0.06] | 0.13 [0.21] | 0.21 [0.57] |
Week 2 | 0.27 [0.15] | 0.15 | 0.18 |
B cells x109/L (median [IQR]) | |||
Pre | N/D | 0.07 [0.20] | 0.07 [0.16] |
Week 1 | 0.49 [0.30] | 0.31 [0.59] | 0.31 [0.25] |
Week 2 | 0.27 [0.06] | 0.71 | 0.17 |
NKT (%) (median [IQR]) | |||
Pre | N/D | 2.90 [8.70] | 1.20 [6.60] |
Week 1 | 2.50 [5.40] | 1.70 [1.20] | 0.70 [4.50] |
Week 2 | 6.80 [16.60] | 4.30 | 1.8 |